Friday 6 November 2026 Export ADPT’s income statement to Excel — free account

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation’s revenue for fiscal 2025 (year ended December 2025) was $277.0 million, up 54.8% from fiscal 2024.

Revenue: −10.7%
EPS: −66.7%
Free cash flow: +201.9%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

27.73 0.90 +3.35%

Follow ADPT

Alert me

Market cap: $4.3B
P/E: 0.0×
Fwd P/E: −49.4×
Dividend yield: —
F-score: 6/9
Altman Z: 2.08
Beneish M: −2.44
Dividend safety: n/a

Overview

Adaptive Biotechnologies Corporation (ADPT) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Adaptive Biotechnologies Corporation (ADPT) trades at a P/S ratio of 14.5×. Over the past ten years it has ranged from 0.0× (June 2019) to 95.2× (December 2020); the current reading is higher than 67% of that period. That is above the Diagnostics & Research industry median of 4.2× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ADPT/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Adaptive Biotechnologies Corporation P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ADPT/metrics/ps-ratio">Adaptive Biotechnologies Corporation (ADPT) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	8.9×	80.37%
FY2024	4.9×	21.94%
FY2023	4.0×	(32.57%)
FY2022	6.0×	(76.49%)
FY2021	25.5×	(67.64%)
FY2020	78.9×	224.20%
FY2019	24.3×	—
FY2018	0.0×	—
FY2017	0.0×	—

Period	P/S ratio	Change
Sep 2026	15.6×	39.76%
Jun 2026	11.1×	52.31%
Mar 2026	7.3×	(17.86%)
Dec 2025	8.9×	(1.40%)
29 more quarters	Free account

Against its own ten years

Low 0.0× High 95.2×

Ten-year median 8.7×

Current reading's percentile 67

Company	P/S ratio
RDNT RadNet, Inc. compare	2.7×
NEO NeoGenomics, Inc. compare	2.7×
VCYT Veracyte, Inc. compare	3.3×
SHC Sotera Health Company compare	3.7×
WGS GeneDx Holdings Corp. compare	4.2×
CDNA CareDx, Inc. compare	8.1×
BLLN BillionToOne, Inc. compare	12.1×
ADPT Adaptive Biotechnologies Corporation	14.5×
GRAL GRAIL, Inc. compare	34.9×
Diagnostics & Research industry median	4.2×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Adaptive Biotechnologies Corporation (ADPT) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ADPT

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ADPT

Stockrow Weekly